This FDA InspectorProfile is a report of relevant audit-related information on Dandan Wang, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.
This InspectorProfile report is updated through and lists Dandan Wang's inspections in 6 countries: United States, New Zealand, Australia, China, Taiwan, and Israel.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Dandan Wang's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Dandan Wang.
Note: The EIR and 483 documents are sold separately.